SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tao,Yuan

第一单位： Institute of Pharmacology & Toxicology , Zhejiang Province Key Laboratory of Anti-Cancer Drug Research , College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , China.

作者： Tao,Yuan ^[1] ; Tianyi,Zhou ^[1] ; Meijia,Qian ^[1] ; Jiamin,Du ^[1] ; Yue,Liu ^[1] ; Jia'er,Wang ^[1] ; Yonghao,Li ^[1] ; Guanghan,Fan ^[1] ; Fangjie,Yan ^[2] ; Xiaoyang,Dai ^[3] ; Xiawei,Li ^[4] ; Yulian,Wu ^[4] ; Xin,Dong ^[5] ; Qiaojun,He ^[4] ; Hong,Zhu ^[1] ; Bo,Yang ^[2]

作者单位： Institute of Pharmacology & Toxicology , Zhejiang Province Key Laboratory of Anti-Cancer Drug Research , College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , China. ^[1] Innovation Institute for Artificial Intelligence in Medicine , Zhejiang University , Hangzhou , China. ^[2] Center for Drug Safety Evaluation and Research of Zhejiang University , Hangzhou , China. ^[3] Second Affiliated Hospital , Zhejiang University School of Medicine , Hangzhou , China. ^[4] Cancer Center of Zhejiang University , Hangzhou , China. ^[5] Westlake Laboratory of Life Sciences and Biomedicine , Hangzhou , China. ^[6]